Research & Development



  小女孩不願意听哥哥說教,三兩口把飯盤里的一小撮飯吃完,丟下飯盤留給母親洗,自己一溜煙的跑了。   又在雲氏的各個商鋪里混跡了一年多,如果單純的以學識來算,在大漢低得可憐的識字人中已經非常的不凡。不卡的无码高清的av   往日的雲氏是寧靜祥和甚至有些慵懶的。超碰在线   “既然如此,為何還要用鎖鏈鎖住他們的雙腳?”   雲瑯點點頭道︰“嫁女兒這種事情,還是您親力親為吧,雲某就不越俎代庖了。”超碰免费公开视频   梁贊見夏侯靜老僕已經走遠了,就把刀子丟給陳銅,快步追了上去。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo